Stocks
Penumbra, Inc.PEN
NYSEHealthcareMedical Devices$336.18+0.36%
Focused on medical devices for neurovascular and peripheral vascular conditions, the company develops technologies used to treat ischemic stroke, pulmonary embolism, and other vascular blockages. Its portfolio includes thrombectomy systems, embolization products, and related devices used in minimall...
Market Cap: $13.2B52W Range: $221.26 – $362.41
Congressional Interest in Penumbra, Inc. (PEN)
2 members of Congress have disclosed 5 trades in Penumbra, Inc. (PEN), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
2
Buys
2
Sells
3
Who in Congress Is Trading PEN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-08 | Rohit Khanna | sell | $1K – $15K |
| 2025-07-10 | Lisa McClain | sell | $1K – $15K |